We are proposing to adopt three electronic clinical quality measures (eCQMs) beginning with the CY 2025 reporting period/FY 2027 payment determination: (1) Hospital HarmPressure Injury eCQM, (2) Hospital HarmAcute Kidney Injury eCQM, and (3) Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Hospital LevelInpatient) eCQM
No payment is collected at delivery
The autism-associated MET receptor tyrosine kinase engages early neuronal growth mechanism and controls glutamatergic circuits development in the forebrain
Real-World Evidence Takes Center Stage One of the most visible trends at EHA 2026 was the growing number of real-world evidence studies presented across multiple disease areas
Okay, so those are the category one are the category two
Since we have now shown that the 1st glutathione-interaction site can serve not only as a scaffold site for GSSR substrates but also as an activator site for GSH for the reduction of non-glutathione disulfide substrates, we would like to suggest to preferably use the terms 1st and 2nd glutathione-interaction site (e.g., in combination with the function as a scaffold or activator) to avoid ambiguities in the future
